Table 1

Baseline subject characteristics by BMI category

BMI category
BMI <25 kg/m2BMI 25–30 kg/m2BMI ≥30 kg/m2p Value
X-ray cohort (GO-BEFORE+GO-FORWARD) (N=1068)
N452357272
Age (years)47.4 (13.2)51.9 (10.5)51.4 (10.7)<0.001
Female, N (%)378 (82%)276 (78%)220 (82%)0.04
Race
 Caucasian, N (%)286 (64%)279 (79%)228 (85%)<0.001
 Asian, N (%)135 (30%)37 (10%)11 (4%)<0.001
BMI (kg/m2)22.0 (2.2)27.4 (1.4)35.2 (5.0)N/A
CRP (mg/dL)1.2 (0.4, 3.3)1.1 (0.4, 2.3)1.1 (0.5, 2.2)0.3
DAS28 (CRP)5.53 (1.09)5.66 (1.02)5.67 (1.00)0.1
CCP-positive, N (%)356 (80%)276 (78%)177 (66%)<0.001
vdHS score12 (2.5, 46.5)7 (2.5, 25)5.5 (1.5, 18)<0.001
Steroid use, N (%)281 (63%)209 (59%)143 (54%)0.05
Active smoking, N (%)72 (18%)69 (23%)42 (17%)0.1
GO-BEFORE MRI substudy (N=317)
N13711168
Age46.552.051.60.0006
Female, N (%)113 (82%)85 (77%)57 (84%)0.4
Race
 Caucasian, N (%)77 (56%)73 (66%)54 (79%)<0.001
 Asian, N (%)55 (40%)23 (21%)6 (9%)<0.001
BMI (kg/m2)21.9 (2.2)27.4 (1.4)35.3 (5.3)N/A
CRP (mg/dL)1.4 (0.4, 3.1)1.2 (0.5, 2.6)0.9 (0.5, 2)0.4
DAS28(CRP)5.61 (1.12)5.63 (1.09)5.55 (0.99)0.9
CCP-positive, N (%)110 (80%)87 (78%)45 (66%)0.07
vdHS score6 (2, 29.3)5.8 (2.9, 16.5)4.8 (1.8, 11.3)0.2
Steroid use, N (%)91 (66%)70 (63%)37 (54%)0.2
Active smoking, N (%)20 (17%)22 (24%)11 (17%)0.3
RAMRIS
 Synovitis9 (5.5, 13.5)11 (6, 13.8)7.5 (4.5, 12.8)0.09
 Bone oedema9 (2.5, 19)6.3 (2.5, 13)4.8 (1.5, 9.8)0.01
 Bone erosion16 (10, 25)14 (11, 21.5)13.5 (9.5, 18.3)0.1
  • BMI, body mass index; CCP, cyclic citrullinated peptide; CRP, C-reactive protein; DAS28, disease activity score 28; RAMRIS, RA MRI score; vdHS, van der Heijde–Sharp.